Natural polyphenols based new therapeutic avenues for advanced biomedical applications

References

• Agrawal M, Biswas A. (2015). Molecular diagnostics of neurodegenerative disorders. Front Mol Biosci, Editorial article, 2(54). doi: 10.3389/fmolb.2015.00054
   Google Scholar
• Agrawal M, Kumar V, Kashyap MP, et al. (2011). Ischemic insult induced apoptotic changes in PC12 cells: Protection by trans resveratrol. Eur J Pharmacol 666:5–11
   PubMed Web of Science ®Google Scholar
• Agrawal M, Kumar V, Singh AK, et al. (2013). Trans-resveratrol protects ischemic PC12 cells by inhibiting the hypoxia associated transcription factors and increasing the levels of antioxidant defense enzymes. ACS Chem Neurosci 4:285–294
   PubMed Web of Science ®Google Scholar
• Albani D, Polito L, Signorini A, Forloni G. (2010). Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36:370–376
   PubMed Web of Science ®Google Scholar
• Athar M, Back JH, Tang X, et al. (2007). Resveratrol: A review of pre-clinical studies for human cancer prevention. Toxicol Appl Pharmacol 224:274–283
   PubMed Web of Science ®Google Scholar
• Augustine N, Goel AK, Sivakumar KC, et al. (2014). Resveratrol-a potential inhibitor of biofilm formation in Vibrio cholerae. Phytomedicine 21:286–289
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. (2006). Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 5:493–506
   PubMed Web of Science ®Google Scholar
• Baxter RA. (2008). Anti-aging properties of resveratrol: Review and report of a potent new antioxidant skin care formulation. J Cosmet Dermatol 7:2–7
   PubMedGoogle Scholar
• Bishayee A. (2009). Cancer prevention and treatment with resveratrol: From rodent studies to clinical trials, cancer. Cancer Prev Res (Phila) 409 (May 2)
   Google Scholar
• Bors W, Heller W, Michel C, Saran M. (1990). Flavonoids as antioxidants: Determination of radical Scavenging efficiencies. Methods Enzymol 186:343–355
   PubMed Web of Science ®Google Scholar
• Botha JJ, Ferreira D, Roux DG. (1978). Condensed tannins: Direct synthesis, structure and absolute configuration of biflavonoids from black wattle bark (mimosa) extract. J Chem Soc Chem Commun. 16:700–702
   Google Scholar
• Brents LK, Medina-Bolivar F, Seely KA, et al. (2012). Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors. Xenobiotica 42:139–156
   PubMed Web of Science ®Google Scholar
• Bringmann G, Gulder T, Gulder T, et al. (2011). Atroposelective total synthesis of axially chiral biaryl natural products. Chem Rev 111:563–639
   PubMed Web of Science ®Google Scholar
• Burns TC, Verfaillie CM, Low WC. (2009). Stem cells for ischemic brain injury: A critical review. J Comp Neurol 515:125–144
   PubMed Web of Science ®Google Scholar
• Chan PH. (2001). Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2–14
   PubMed Web of Science ®Google Scholar
• Chander V, Chopra K. (2005). Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. J Vasc Surg 42:1198–1205
   PubMed Web of Science ®Google Scholar
• Clark D, Tuor UI, Thompson R, et al. (2012). Protection against recurrent stroke with resveratrol: Endothelial protection. PLoS One 7:e47792
   PubMedGoogle Scholar
• Deffieux D, Natangelo A, Malik G, et al. (2011). First and biomimetic total synthesis of a member of the C-glucosidic subclass of ellagitannins, 5-O-desgalloyl-epi-punicacortein A. Chem Commun (Camb.) 47:1628–1630
   PubMed Web of Science ®Google Scholar
• Dennell R. (1947). The occurrence and significance of phenolic hardening in the newly formed cuticle of Crustacea decapoda. Proc R S B 134:485–503
   Web of Science ®Google Scholar
• Ding DF, You N, Wu XM, et al. (2010). Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK. Am J Nephrol 31:363–374
   PubMed Web of Science ®Google Scholar
• Wen PD, Nan LL, Gao DK, et al. (2008). Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg 48:714
   Google Scholar
• Feldman K, Ensel SM. (1994). Ellagitannin chemistry. Preparative and mechanistic studies of the biomimetic oxidative coupling of galloyl esters. J Amer Chem Soc 116:3357–3366
   Web of Science ®Google Scholar
• Feldman KS, Lawlor MD, Sahasrabudhe K. (2000). Ellagitannin chemistry. Evolution of a three-component coupling strategy for the synthesis of the dimeric ellagitannin coriariin A and a dimeric gallotannin analogue. J Org Chem 65:8011–8019
   PubMed Web of Science ®Google Scholar
• Feldman KS. (2004). Recent progress in ellagitannin chemistry, 4th Tannin Conference held at the Fall Meeting of the American Chemical Society, Phytochemistry; Philadelphia, 66:1984–2000
   Google Scholar
• Fernández-Mar MI, Mateos R, García-Parrilla MC, et al. (2012). Bioactive compounds in wine: Resveratrol, hydroxytyrosol and melatonin: A review. Food Chem 130:797–813
   Web of Science ®Google Scholar
• Giovannelli L, Pitozzi V, Jacomelli M, et al. (2011). Protective effects of resveratrol against senescence-associated changes in cultured human fibroblasts. J Gerontol A Biol Sci Med Sci 66:9–18
   PubMed Web of Science ®Google Scholar
• Giovannini L, Migliori M, Longoni BM, et al. (2001). Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol 37:262–270
   PubMed Web of Science ®Google Scholar
• Greer AK, Madadi NR, Bratton SM, et al. (2014). Novel resveratrol-based substrates for human hepatic, renal, and intestinal UDP-glucuronosyltransferases. Chem Res Toxicol 27:536–545
   PubMed Web of Science ®Google Scholar
• Han YS, Bastianetto S, Dumont Y, Quirion R. (2006). Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther 318:238–245
   PubMed Web of Science ®Google Scholar
• Harper CE, Patel BB, Wang J, et al. (2007). Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 28:1946–1953
   PubMed Web of Science ®Google Scholar
• Hart JH, Hillis WE. (1974). Inhibition of wood-rotting fungi by stilbenes and other polyphenols in Eucalyptus sideroxylon. Phytopathology 64:939–948
   Web of Science ®Google Scholar
• Hubbard BP, Gomes AP, Dai H, et al. (2013). Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 339:1216–1219
   PubMed Web of Science ®Google Scholar
• Itoh T, Chika J, Shirakami SS, et al. (1996). Synthesis of trideca-O-methyl-alpha-pedunculagin. Diastereo-favoritism studies on intramolecular ester-cyclization of axially chiral diphenic acids with carbohydrate core. J Org Chem 61:3700–3705
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220
   PubMed Web of Science ®Google Scholar
• Jendekova L, Kojsova S, Andriantsitohaina R, Pechanova O. (2006). The time-dependent effect of provinolsTM on brain NO synthase activity in L-NAME-induced hypertension. Physiol Res 55:31–37
   Google Scholar
• Lee J, Ryu YKSY, et al. (2014). Resveratrol oligomers inhibit biofilm formation of Escherichia coli O157:H7 and Pseudomonas aeruginosa. J Nat Prod 77:168–172
   PubMed Web of Science ®Google Scholar
• Khanbabaee K, Grosser M. (2003). An efficient total synthesis of pedunculagin by using a twofold intramolecular double esterification strategy. Eur J Org Chem 11:2128–2131
   Web of Science ®Google Scholar
• Khushwant S, Bhullar HP., Rupasinghe V. (2013). Polyphenols: Multipotent therapeutic agents in neurodegenerative diseases. Oxid Med Cell Longev 2013:891748
   PubMedGoogle Scholar
• Kimura Y, Okuda H. (2001). Resveratrol isolated from polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131:1844–1849
   PubMed Web of Science ®Google Scholar
• Kitada M, Koya D. (2013). Renal protective effects of resveratrol. Oxid Med Cell Longev 2013:568093
   PubMed Web of Science ®Google Scholar
• Kitada M, Zhang Z, Mima A, King GL. (2010). Molecular mechanisms of diabetic vascular complications. J Diabetes Investig 1:77–89
   PubMed Web of Science ®Google Scholar
• Kovacsova M, Barta A, Parohova J, et al. (2010). Neuroprotective mechanisms of natural polyphenolic compounds. Act Nerv Super 52:181–186
   Google Scholar
• Kozikowski AP, Tückmantel W, Boettcher G, Romanczyk LJ. Jr (2003). Studies in polyphenol chemistry and bioactivity. 4. (1) Synthesis of trimeric, tetrameric, pentameric, and higher oligomeric epicatechin-derived procyanidins having all-4β,8-interflavan connectivity and their inhibition of cancer cell growth through cell cycle arrest. J Org Chem 68:1641–1658
   PubMed Web of Science ®Google Scholar
• Krasnow MN, Murphy TM. (2004). Polyphenol glucosylating activity in cell suspensions of grape (Vitis vinifera). J Agr Food Chem 52:3467–3472
   PubMed Web of Science ®Google Scholar
• Krohn K, Ahmed I, John M, et al. (2010). Stereoselective synthesis of benzylated prodelphinidins and their diastereomers with use of the Mitsunobu reaction in the preparation of their gallocatechin precursors. Eur J Org Chem 2010:2544–2554
   Web of Science ®Google Scholar
• Kundu JK, Surh YJ. (2008). Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett 269:243–261
   PubMed Web of Science ®Google Scholar
• Leonard SS, Xia C, Jiang BH, et al. (2003). Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 309:1017–1026
   PubMed Web of Science ®Google Scholar
• Leonardo CC, Agrawal M, Singh N, et al. (2013). Oral administration of the flavanol (-)-epicatechin bolsters endogenous protection against focal ischemia through the Nrf2 cytoprotective pathway. Eur J Neurosci 38:3659–3668
   PubMed Web of Science ®Google Scholar
• Lipshutz BH, Liu ZP, Kayser F. (1994). Cyanocuprate-mediated intramolecular biaryl couplings applied to an ellagitannin - synthesis of (+)-O-permethyltellimagrandin II. Tet Lett 35:5567–5570
   Web of Science ®Google Scholar
• Malek SRA. (1961). Polyphenols and their quinone derivatives in the cuticle of the desert locust, Schistocerca gregaria (Forskål). Comp Biochem Physiol 2:35–77
   Web of Science ®Google Scholar
• Nakai S. (2000). Myriophyllum spicatum-released allelopathic polyphenols inhibiting growth of blue-green algae Microcystis aeruginosa. Water Res 34:3026–3032
   Web of Science ®Google Scholar
• Nelson TD, Meyers AI. (1994). A rapid total synthesis of an ellagitannin. J Org Chem 59:2577–2580
   Web of Science ®Google Scholar
• O'Connor DJ, Wong RWK, Rabie ABM. (2011). Resveratrol inhibits periodontal pathogens in vitro. Phytother Res 25:1727–1731
   PubMed Web of Science ®Google Scholar
• Ohmori K, Shono T, Hatakoshi Y, et al. (2011). Integrated synthetic strategy for higher catechin oligomers. Angew Chem Int Ed Engl 50:4862–4867
   PubMed Web of Science ®Google Scholar
• Okada Y, Nakamura YOY, et al. (2012). Dietary resveratrol prevents the development of food allergy in mice. PLoS One 7:e44338
   PubMedGoogle Scholar
• Pandey KB, Rizvi SI. (2010). Protective effect of resveratrol on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative insult. Phytother Res 1:11–14
   Web of Science ®Google Scholar
• Park SJ, Ahmad F, Philp A, et al. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148:421–433
   PubMed Web of Science ®Google Scholar
• Plumed-Ferrer C, Väkeväinen K, Komulainen H, et al. (2013). The antimicrobial effects of wood-associated polyphenols on food pathogens and spoilage organisms. Int J Food Microbiol. 164:99–107
   PubMed Web of Science ®Google Scholar
• Popa V, Dumitru M, Volf I, Anghel N. (2008). Lignin and polyphenols as allelochemicals. Ind Crops Prod 27:144–149
   Web of Science ®Google Scholar
• Pouysegu L, Deffieux D, Gaelle GM, et al. (2011). Synthesis of ellagitannin natural products. Nat Prod Rep 28:853–874
   PubMed Web of Science ®Google Scholar
• Price NL, Gomes AP, Ling AJY, et al. (2012). SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15:675–690
   PubMed Web of Science ®Google Scholar
• Quideau S. (2011). Organic chemistry: Triumph for unnatural synthesis. Nature 474:459–460
   PubMed Web of Science ®Google Scholar
• Quideau SP, Deffieux D, Douat-Casassus CL, Pouységu L. (2011). Plant polyphenols: Chemical properties, biological activities, and synthesis. Angew Chem Int Ed 50:586–621
   PubMed Web of Science ®Google Scholar
• Riley PA. (1994). Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 65:27–33
   PubMed Web of Science ®Google Scholar
• Robb EL, Stuart JA. (2010). Trans-resveratrol as a neuroprotectant. Molecules 15:1196–1212
   PubMed Web of Science ®Google Scholar
• Sabolovic N, Humbert AC, Radominska-Pandya A, Magdalou J. (2006). Resveratrol is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in CaCO2 cells. Biopharm Drug Dispos 27:181–189
   PubMed Web of Science ®Google Scholar
• Sakata Y, Zhuang H, Kwansa H, et al. (2010). Resveratrol protects against experimental stroke: Putative neuroprotective role of heme oxygenase 1. Exp Neurol 224:325–329
   PubMed Web of Science ®Google Scholar
• Saleh MC, Connell BJ, Rajagopal D, et al. (2014). Co-administration of resveratrol and lipoic acid, or their synthetic combination, enhances neuroprotection in a rat model of ischemia/reperfusion. PLoS One 9:e87865
   PubMed Web of Science ®Google Scholar
• Singh N, Agrawal M, Dore S. (2013). Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models. ACS Chem Neurosci, 4:1151–1162
   PubMed Web of Science ®Google Scholar
• Smoliga JM, Baur JA, Hausenblas HA. (2011). Resveratrol and health-a comprehensive review of human clinical trials. Mol Nutr Food Res 55:1129–1141
   PubMed Web of Science ®Google Scholar
• Snyder SA, Gollner A, Chiriac MI. (2011). Regioselective reactions for programmable resveratrol oligomer synthesis. Nature 474:461–466
   PubMed Web of Science ®Google Scholar
• Steinberg GR, Kemp BE. (2009). AMPK in health and disease. Physiol Rev 89:1025–1078
   PubMed Web of Science ®Google Scholar
• Tanner G, Francki KT, Abrahams S, et al. (2003). Proanthocyanidin biosynthesis in plants. J Biol Chem 278:31647–31656
   PubMed Web of Science ®Google Scholar
• Tikoo K, Singh K, Kabra D, et al. (2008). Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. Free Radical Res 42:397–404
   PubMed Web of Science ®Google Scholar
• Tsai SK, Hung LM, Fu YT, et al. (2007). Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 46:346–353
   PubMed Web of Science ®Google Scholar
• Wigglesworth VB. (1988). The source of lipids and polyphenols for the insect cuticle: The role of fat body, oenocytes and oenocytoids. Tissue Cell 20:919–932
   PubMed Web of Science ®Google Scholar
• Zadak Z, Hyspler R, Ticha A, et al. (2009). Antioxidants and vitamins in clinical conditions. Physiol Res 58:13–17
   PubMed Web of Science ®Google Scholar
• Zetterström CE, Hasselgren J, Salin O, et al. (2013). The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the Gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa. PLoS One 8:1–12
   Web of Science ®Google Scholar